<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/empatica-fda-clearance-parkinsons-disease-monitoring-platform</loc>
    <lastmod>2026-08-21T22:17:53+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Empatica Gains FDA Clearance for Continuous Parkinson's Disease Monitoring Platform</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6de9f08c-68a3-4ccc-84e0-79daa958c4f4/01c6e2f6-a87c-47e1-bfcf-96895ca9972a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-finalizes-therapeutic-equivalence-guidance-orange-book-te-codes</loc>
    <lastmod>2026-08-21T22:19:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>FDA Finalizes Therapeutic Equivalence Guidance Changing Orange Book TE Codes</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6de9f08c-68a3-4ccc-84e0-79daa958c4f4/e6afd9e7-9a9b-4405-9e90-bb8a67dbc7c3.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-publishes-55-product-specific-guidances-generic-drug-anda-development</loc>
    <lastmod>2026-08-21T22:20:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>FDA Issues 55 New Guidances to Speed Up Generic Drugs Development</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6de9f08c-68a3-4ccc-84e0-79daa958c4f4/923e4b69-bd9d-4609-9d6e-c8018e34872a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/zydus-fda-approval-ascorbic-acid-injection-anda-448</loc>
    <lastmod>2026-08-21T22:17:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Zydus Gains FDA Approval for Ascorbic Acid Injection, Lifting ANDA Portfolio to 448</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/9dc5f756-21c1-4e87-84a5-c217a766c77e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/merck-moderna-mrna-cancer-vaccine-phase-3-primary-endpoint-melanoma</loc>
    <lastmod>2026-08-21T22:23:17+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Merck and Moderna Achieve Phase 3 Primary Endpoint with mRNA Cancer Vaccine in Melanoma</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/d5d929e1-5f6b-49c6-8577-41d97866941e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cadila-pharma-appoints-surender-narain-singh-vp-business-development</loc>
    <lastmod>2026-08-21T22:22:51+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Cadila Pharma Appoints Surender Narain Singh as VP of Business Development</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/0bd58ff8-a23d-4c59-ade3-03d006d0c868.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/johnson-johnson-ec-approval-teclistamab-daratumumab-second-line-rrmm</loc>
    <lastmod>2026-08-21T22:16:55+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Johnson &amp; Johnson Wins EU Approval for Teclistamab Combo in Myeloma</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/267237f0-ce9f-46d1-b578-8aae411e9b20.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ipsen-acquires-kartos-therapeutics-navtemadlin-mdm2-inhibitor-oncology</loc>
    <lastmod>2026-08-21T22:15:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Ipsen Acquires Kartos Therapeutics, Adding  Navtemadlin to Oncology Pipeline</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/6942e1bc-c8cb-43d7-8602-4f918a90bda4.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/auropeptides-clears-fda-inspection-minor-observation-corrective-action</loc>
    <lastmod>2026-08-21T22:13:51+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>AuroPeptides Clears FDA Inspection With Just One Observation</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/1dc36598-cdf9-4ded-a4d6-9503cd7e850d/f1c2cdc8-005f-4e7b-81ba-2a749c0d6785.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbott-670-million-nec-settlement-preterm-formula-2026</loc>
    <lastmod>2026-08-21T11:23:20+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Abbott Settles 2,000 NEC Claims for $670M, Shifts Legal Strategy</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/10338c10-09ed-4818-8a96-28939d584f25/97d381df-c1e9-4854-8768-86a0d85bcddd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/tilray-expands-cannabis-production-capacity-275-tonnes-quebec-portugal</loc>
    <lastmod>2026-08-21T10:58:50+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-21T00:00:00+05:30</news:publication_date>
      <news:title>Tilray Expands Annual Cannabis Production Capacity to 275 Tonnes Across Quebec and Portugal</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TilrayExpandsAnnualCannabisCultivationCapacityAcrossEU-GMP-CertifiedSites20260821105841.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fibrobiologics-secures-australian-patent-cannabidiol-fibroblast-disc-degeneration</loc>
    <lastmod>2026-08-21T11:00:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>FibroBiologics Secures Australian Patent Acceptance for Cannabidiol-Fibroblast Combination in Disc Degeneration</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FibroBiologicsSecuresAustralianPatentAcceptanceforCannabidiol-FibroblastCombinationinDiscDegeneration20260821110027.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/genentech-750m-hillsboro-fill-finish-facility-us-device-manufacturing</loc>
    <lastmod>2026-08-21T11:07:49+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Genentech Invests $750M in Hillsboro Fill-Finish Facility to Expand U.S. Device Manufacturing</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/519f449a-a862-4b64-a8fc-753923cf7059.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/pacbio-launches-sprq-nx-vega-benchtop-hifi-sequencing-21-cfr-part-11</loc>
    <lastmod>2026-08-21T11:01:02+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>PacBio Launches SPRQ-Nx Chemistry on Vega Benchtop System with 21 CFR Part 11 Audit Logging</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/PacBioLaunchesSPRQ-NxChemistryonVegaBenchtopSystemwith21CFRPart11AuditLogging20260821110057.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/optimal-balance-pharmacy-recalls-compounded-glutathione-elevated-endotoxin</loc>
    <lastmod>2026-08-21T11:00:01+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Optimal Balance Pharmacy Recalls Compounded Glutathione Vials After Elevated Endotoxin Levels Detected</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/OptimalBalancePharmacyRecallsCompoundedGlutathioneVialsAfterElevatedEndotoxinLevelsDetected20260821105956.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ultragenyx-fda-accelerated-approval-genglycos-gsd1a-gene-therapy</loc>
    <lastmod>2026-08-21T10:59:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Ultragenyx Gains FDA Accelerated Approval for Genglycos in GSD1a, First-Ever Gene Therapy for the Disease</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/b75b93e2-f19d-4b57-b8ba-8c9e442d5dfd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/tilray-expands-cannabis-cultivation-capacity-275-metric-tonnes-eu-gmp</loc>
    <lastmod>2026-08-21T11:02:02+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Tilray Expands Annual Cannabis Cultivation Capacity Across EU-GMP-Certified Sites</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TilrayExpandsAnnualCannabisCultivationCapacityAcrossEU-GMP-CertifiedSites20260821110155.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/kyverna-therapeutics-gains-rmat-designation-miv-cel-progressive-multiple-sclerosis</loc>
    <lastmod>2026-08-21T11:01:32+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Kyverna Therapeutics Gains RMAT Designation for Miv-Cel in Progressive Multiple Sclerosis</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/KyvernaTherapeuticsGainsRMATDesignationforMiv-CelinProgressiveMultipleSclerosis20260821110129.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/strides-pharma-bengaluru-facility-eir-us-fda-inspection</loc>
    <lastmod>2026-08-21T11:03:33+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Strides Pharma Gains FDA Report for Bengaluru Manufacturing Facility</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/eb6123db-aee3-47e4-88e6-355debe5dcf7/341ebe53-8d59-4a72-a1fa-9a07b2a8e798.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/glenmark-us-fda-approval-fluticasone-propionate-nasal-spray</loc>
    <lastmod>2026-08-21T11:02:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Glenmark Gains US FDA Approval For Generic Fluticasone Nasal Spray</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/GlenmarkGainsUSFDAApprovalForGenericFluticasoneNasalSpray20260821110231.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/visufarma-exclusive-european-licensing-deal-yuvezzi-presbyopia</loc>
    <lastmod>2026-08-21T11:03:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>VISUfarma Signs European Licensing Deal For YUVEZZI</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/VISUfarmaSignsEuropeanLicensingDealForYUVEZZI20260821110257.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/telix-pharmaceuticals-h1-2026-results-radiopharmaceutical-revenue-growth</loc>
    <lastmod>2026-08-20T11:56:48+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Telix Reports 22% Revenue Growth as Radiopharma Portfolio Scales</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ascentage-pharma-nine-phase-iii-trials-revenue-growth-h1-2026</loc>
    <lastmod>2026-08-20T11:56:51+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Ascentage Pharma Runs Nine Phase III Trials Amid 29% H1 Growth</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a4478e28-2fa6-4afa-ac53-7f97056ff985/8a55d559-1301-4179-a9e6-64910c4a5fee.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/b-braun-medical-recalls-excel-lactated-ringers-1000ml-particulate-contamination</loc>
    <lastmod>2026-08-21T11:06:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>B. Braun Recalls Lactated Ringers 1000mL Over Contamination</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/B.BraunRecallsLactatedRingers1000mLOverContamination20260821110548.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ultragenyx-fda-accelerated-approval-genglycos-gsdia</loc>
    <lastmod>2026-08-21T11:06:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Ultragenyx Wins FDA Approval for Genglycos in GSDIa Patients</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/UltragenyxWinsFDAApprovalforGenglycosinGSDIaPatients20260821110643.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/regeneron-fda-approval-pasatru-garetosmab-fop-home-infusion</loc>
    <lastmod>2026-08-21T11:04:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>Regeneron Wins FDA Approval for Pasatru in FOP, Enables Home Infusion</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/RegeneronWinsFDAApprovalforPasatruinFOP,EnablesHomeInfusion20260821110356.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-completes-pdufa-vii-cmc-deliverables-accelerated-development</loc>
    <lastmod>2026-08-21T11:08:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-20T00:00:00+05:30</news:publication_date>
      <news:title>FDA Completes PDUFA VII CMC Deliverables, Sets Submission Benchmarks</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDACompletesPDUFAVIICMCDeliverables,SetsSubmissionBenchmarks20260821110827.png</image:loc>
    </image:image>
  </url>
</urlset>